Conclusion
In this retrospective analysis, concomitant Impella® to ECMO support in
eCPR patients was associated with significantly lower in-hospital
mortality. Also, weaning of VA-ECMO was more often successful in the
ECMO+Impella® group. ECMO+Impella® group showed significantly
higher rates of blood transfusions and acute kidney failure requiring
dialysis.
The realization of a simultaneous mechanical circulatory assist device
might be a beneficial therapy option in eCPR patients. Further studies
are needed to evaluate the clinical relevance and impact of Impella®
devices in eCPR patients.